Loading
Food and Beverage
5 min read
Areas of Expertise :
Advertising, Marketing, Consumer Survey, Food And Drug Administration (FDA), Labels And Warnings
Published Date:
Last Modified Date:
Jurisdiction:
Federal. U.S. Supreme Court
POM Wonderful LLC v. Coca-Cola Co. is a U.S. Supreme Court case that examined the intersection of FDA labeling regulations and competitor false advertising claims under the Lanham Act. The dispute began when POM Wonderful argued that Coca-Cola’s “Pomegranate Blueberry Flavored Blend of Five Juices” misled consumers by emphasizing pomegranate and blueberry on its label, even though the juice was primarily composed of apple and grape (over 99%).
In 2014, the Supreme Court clarified that compliance with FDA regulations does not prevent competitors from bringing false advertising lawsuits. The decision reinforced that the FDCA and the Lanham Act address different concerns: FDA rules focus on public health, while the Lanham Act addresses unfair competition and misleading advertising. This ruling remains a critical precedent in advertising law, marketing litigation, and regulatory compliance.
POM Wonderful filed its complaint in 2008, alleging that Coca-Cola’s “Pomegranate Blueberry Flavored Blend of Five Juices” label violated the Lanham Act. POM argued that Coca-Cola’s product name and packaging led consumers to believe the beverage contained primarily pomegranate and blueberry juices, even though it was 99.4% apple and grape with only trace amounts of the highlighted fruits. The complaint sought damages and injunctive relief, framing the dispute as a matter of misleading advertising in the food and beverage industry.
In early proceedings, the district court limited POM’s Lanham Act theories regarding the product’s name and labeling. In May 2010, the Central District of California granted partial summary judgment to Coca-Cola on those issues, holding that FDA labeling regulations precluded competitors from challenging product names already overseen by the agency. The court allowed POM’s non-label advertising and marketing claims to proceed, but POM conceded it could not succeed without the labeling aspect, leading to judgment for Coca-Cola.
On appeal, the Ninth Circuit affirmed the district court’s ruling. The panel concluded that POM’s Lanham Act challenge to the product name and labeling was barred out of deference to FDA authority. The court also vacated and remanded state-law standing issues. This appellate decision significantly narrowed POM’s ability to pursue its allegations against Coca-Cola.
The Supreme Court granted certiorari and heard oral arguments on April 21, 2014. On June 12, 2014, the Court reversed 8–0 (Justice Breyer recused). Justice Anthony Kennedy, writing for the Court, emphasized that the FDCA and the Lanham Act are not mutually exclusive. FDA oversight did not foreclose competitor actions under the Lanham Act, as each statute serves distinct purposes: the FDCA regulates food labeling for public health, while the Lanham Act protects businesses against unfair competition. The ruling reopened the path for POM’s claims to be heard on the merits and clarified a key principle in advertising litigation.
Following the Supreme Court’s ruling, the case returned to the district court for trial. Jury proceedings occurred March 11–18, 2016, focusing on whether Coca-Cola’s labeling was likely to mislead consumers and harm POM’s sales. On March 21, 2016, the jury found in favor of Coca-Cola, concluding that POM had not shown the label was likely to mislead a substantial portion of consumers or that it caused competitive injury. This verdict effectively ended the eight-year litigation, demonstrating the challenges of substantiating false advertising claims even when statutory barriers to suit are removed.
Court:
Supreme Court of the United States
Case Name:
POM Wonderful LLC v. Coca-Cola Co.
Advertising and Marketing
Deceptive Advertising
Consumer
Food Labels
FDA Regulation
Branding
Marketing Research
Mislabeling
Beverages Industry
Lanham Act
POM Wonderful LLC v. Coca-Cola Co. is a U.S. Supreme Court case that examined the intersection of FDA labeling regulations and competitor false advertising claims under the Lanham Act. The dispute began when POM Wonderful argued that Coca-Cola’s “Pomegranate Blueberry Flavored Blend of Five Juices” misled consumers by emphasizing pomegranate and blueberry on its label, even though the juice was primarily composed of apple and grape (over 99%).
In 2014, the Supreme Court clarified that compliance with FDA regulations does not prevent competitors from bringing false advertising lawsuits. The decision reinforced that the FDCA and the Lanham Act address different concerns: FDA rules focus on public health, while the Lanham Act addresses unfair competition and misleading advertising. This ruling remains a critical precedent in advertising law, marketing litigation, and regulatory compliance.
POM Wonderful filed its complaint in 2008, alleging that Coca-Cola’s “Pomegranate Blueberry Flavored Blend of Five Juices” label violated the Lanham Act. POM argued that Coca-Cola’s product name and packaging led consumers to believe the beverage contained primarily pomegranate and blueberry juices, even though it was 99.4% apple and grape with only trace amounts of the highlighted fruits. The complaint sought damages and injunctive relief, framing the dispute as a matter of misleading advertising in the food and beverage industry.
In early proceedings, the district court limited POM’s Lanham Act theories regarding the product’s name and labeling. In May 2010, the Central District of California granted partial summary judgment to Coca-Cola on those issues, holding that FDA labeling regulations precluded competitors from challenging product names already overseen by the agency. The court allowed POM’s non-label advertising and marketing claims to proceed, but POM conceded it could not succeed without the labeling aspect, leading to judgment for Coca-Cola.
On appeal, the Ninth Circuit affirmed the district court’s ruling. The panel concluded that POM’s Lanham Act challenge to the product name and labeling was barred out of deference to FDA authority. The court also vacated and remanded state-law standing issues. This appellate decision significantly narrowed POM’s ability to pursue its allegations against Coca-Cola.
The Supreme Court granted certiorari and heard oral arguments on April 21, 2014. On June 12, 2014, the Court reversed 8–0 (Justice Breyer recused). Justice Anthony Kennedy, writing for the Court, emphasized that the FDCA and the Lanham Act are not mutually exclusive. FDA oversight did not foreclose competitor actions under the Lanham Act, as each statute serves distinct purposes: the FDCA regulates food labeling for public health, while the Lanham Act protects businesses against unfair competition. The ruling reopened the path for POM’s claims to be heard on the merits and clarified a key principle in advertising litigation.
Following the Supreme Court’s ruling, the case returned to the district court for trial. Jury proceedings occurred March 11–18, 2016, focusing on whether Coca-Cola’s labeling was likely to mislead consumers and harm POM’s sales. On March 21, 2016, the jury found in favor of Coca-Cola, concluding that POM had not shown the label was likely to mislead a substantial portion of consumers or that it caused competitive injury. This verdict effectively ended the eight-year litigation, demonstrating the challenges of substantiating false advertising claims even when statutory barriers to suit are removed.
These experts analyze how consumers perceive product packaging, branding, and advertising claims. They provide insights into whether marketing strategies could influence purchasing decisions or create potentially misleading impressions.
Experts in food science and product labeling offer perspectives on FDA regulations, industry labeling practices, and compliance standards. They assess how ingredient disclosures and product names align with regulatory requirements and consumer expectations.
Survey experts design and interpret consumer perception studies that measure how advertising messages are received by the public. Their findings can help determine whether a substantial portion of consumers may be misled by product claims.
These experts evaluate advertising strategies, promotional campaigns, and brand messaging. They often compare business practices to industry standards, offering opinions on whether marketing communications support fair competition or risk deceptive outcomes.
POM Wonderful LLC v. Coca-Cola Co. remains a landmark decision in advertising law. The Supreme Court’s 2014 ruling affirmed that FDA compliance does not shield companies from Lanham Act claims, reinforcing the role of competitor-driven enforcement in maintaining truthful marketing. However, the 2016 jury verdict in favor of Coca-Cola demonstrated the difficulty of proving consumer deception in false advertising disputes.
The case underscores the dual challenges of navigating regulatory frameworks while meeting evidentiary burdens. It also illustrates the importance of expert witness contributions in evaluating advertising practices, consumer behavior, and labeling standards in FDA-regulated industries.
What was the main issue in POM Wonderful v. Coca-Cola?
The key issue was whether FDA compliance barred competitors from pursuing Lanham Act false advertising claims. The Supreme Court ruled that it did not.
Did POM ultimately win the case?
No. Although POM succeeded at the Supreme Court in preserving its right to sue, the jury later ruled in favor of Coca-Cola, ending the case.
Why is this case important in advertising and marketing law?
It clarified that FDA labeling regulations and Lanham Act claims function independently, allowing competitors to challenge misleading advertising even when labels meet FDA standards.
What role do expert witnesses play in false advertising disputes?
Expert witnesses contribute insights into consumer behavior, labeling compliance, advertising practices, and survey evidence, all of which help courts assess whether advertising is deceptive under the Lanham Act.
These experts analyze how consumers perceive product packaging, branding, and advertising claims. They provide insights into whether marketing strategies could influence purchasing decisions or create potentially misleading impressions.
Experts in food science and product labeling offer perspectives on FDA regulations, industry labeling practices, and compliance standards. They assess how ingredient disclosures and product names align with regulatory requirements and consumer expectations.
Survey experts design and interpret consumer perception studies that measure how advertising messages are received by the public. Their findings can help determine whether a substantial portion of consumers may be misled by product claims.
These experts evaluate advertising strategies, promotional campaigns, and brand messaging. They often compare business practices to industry standards, offering opinions on whether marketing communications support fair competition or risk deceptive outcomes.
POM Wonderful LLC v. Coca-Cola Co. remains a landmark decision in advertising law. The Supreme Court’s 2014 ruling affirmed that FDA compliance does not shield companies from Lanham Act claims, reinforcing the role of competitor-driven enforcement in maintaining truthful marketing. However, the 2016 jury verdict in favor of Coca-Cola demonstrated the difficulty of proving consumer deception in false advertising disputes.
The case underscores the dual challenges of navigating regulatory frameworks while meeting evidentiary burdens. It also illustrates the importance of expert witness contributions in evaluating advertising practices, consumer behavior, and labeling standards in FDA-regulated industries.
What was the main issue in POM Wonderful v. Coca-Cola?
The key issue was whether FDA compliance barred competitors from pursuing Lanham Act false advertising claims. The Supreme Court ruled that it did not.
Did POM ultimately win the case?
No. Although POM succeeded at the Supreme Court in preserving its right to sue, the jury later ruled in favor of Coca-Cola, ending the case.
Why is this case important in advertising and marketing law?
It clarified that FDA labeling regulations and Lanham Act claims function independently, allowing competitors to challenge misleading advertising even when labels meet FDA standards.
What role do expert witnesses play in false advertising disputes?
Expert witnesses contribute insights into consumer behavior, labeling compliance, advertising practices, and survey evidence, all of which help courts assess whether advertising is deceptive under the Lanham Act.
Advertising and Marketing
Deceptive Advertising
Consumer
Food Labels
FDA Regulation
Branding
Marketing Research
Mislabeling
Beverages Industry
Lanham Act
Wage And Hour Disputes, +4
Food and Beverage
Food And Beverage, +4
Food and Beverage